Articles Related to Candidiasis
Invasive Candidiasis in Neonatal Intensive Care Unit
Candidemia is the third most common cause of hospital acquired infection affecting infants in the neonatal intensive
care unit (NICU).
Assessment of the Efficacy, Safety and Cost-Effectiveness of Micafungin Compared to Caspofungin and Low Dose Liposomal Amphotericin B for the Treatment of Candidaemia and Clinically Diagnosed Invasive Candidiasis: A Retrospective Audit
Despite several studies having highlighted that candidaemia and invasive fungal disease (IFD) are associated with high mortality and increased costs, there are currently few published studies which provide an insight into real-life practice of invasive candidal diseases. In a medium-sized district general hospital in the UK we sought to compare the efficacy, safety and treatment cost of micafungin versus caspofungin and low dose of liposomal amphotericin B (L-AmB) 1mg/kg/day for the treatment of confirmed candidaemia or clinically diagnosed invasive fungal disease (CDIFD). In the present retrospective audit, a total of 126 patients with candidaemia or CDIFD were reviewed from hospital records and 94 were included in our audit.
Candidiasis Diagnosed at the University Hospital of Constantine, Algeria
Candida species are ubiquitous fungi and the most common fungal pathogens affecting humans. The aim of this study were to evaluate the epidemiology and describe the characteristics of patients with documented infections superficial or invasive caused by Candida species isolates in a Constantine teaching hospital and determine the risk factors.